latest news releases from the newsroom
American Ammunition Inc.
American Ammunition Ships 225,000 Round Order To Dominican Republic Distributor
MIAMI, Dec. 1, 2003 (PRIMEZONE) -- American Ammunition, Inc. (OTCBB:AAMI) announced today that it shipped 225,000 rounds to its Dominican Republic distributor after receiving U.S. State Department approval for export. This shipment is a part of a 500,000 round export order received earlier in the year and announced March 31, 2003. In the last thirty (30) days AAMI has shipped more than 3,000,000 rounds of ammunition for export.
FTS Wireless, Inc.
FTS Wireless Chairman and CEO Interviewed on Business Talk Radio Show
YARDLEY, Pa., Dec. 01,2003 (PRIMEZONE) -- FTS Wireless, Inc., (OTCBB:FLIP) a next generation wireless acquisition and development company and wholly owned subsidiary of FTS Apparel, Inc., would like to inform its shareholders and other interested parties that its Chairman and Chief Executive Officer Mr. Scott Gallagher was interviewed on a financial program that ran last night on some 350 radio channels across the U.S. The program also featured an interview with noted fund manager and Chairman of Gabelli Asset Management, Inc. (NYSE:GBL) Mr. Mario Gabelli.
CDMA Development Group
CDG Congratulates KDDI on Deployment of CDMA2000 1xEV-DO
COSTA MESA, Calif., Dec. 1, 2003 (PRIMEZONE) -- The CDMA Development Group (CDG) (www.cdg.org) congratulates KDDI on the launch of CDMA2000(r) 1xEV-DO services in major metropolitan areas in Japan. Branded CDMA 1X WIN, the new service complements KDDI's already successful EZWeb product and will enable the operator to offer most advanced broadband applications. KDDI is the ninth carrier worldwide to commercially deploy CDMA2000 1xEV-DO.
Medivir and Peptimmune announce EU patent on uses of cathepsin S
HUDDINGE, Sweden, Dec. 1, 2003 (PRIMEZONE) -- Peptimmune, Inc. and Medivir today announced the issuance of a European patent claiming uses of Cathepsin S inhibitors in therapeutic formulations for suppressing immune responses. European patent 0912601 issued on November 26, 2003, and is entitled "SUPPRESSION OF IMMUNE RESPONSE VIA INHIBITION OF CATHEPSIN S."